Cowen And Company »

Lexaria Bioscience shares owned by Cowen And Company

Quarter-by-quarter ownership of Lexaria Bioscience (LEXX) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Lexaria Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Lexaria Bioscience held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexaria Bioscience by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $320k 256k 1.25

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Lexaria Bioscience

Invenomic Capital Management
Vanguard Group
Raymond James Financial Services Advisors
Citadel Advisors
Welch Group
Wealth Enhancement Advisory Services
Oakworth Capital
UBS Group
ADAR1 Capital Management
Wells Fargo & Company
Jpmorgan Chase & Co
Advisor Group Holdings
Aspire Private Capital
Royal Bank of Canada
Farther Finance Advisors

View all funds holding Lexaria Bioscience